TAM (Treatments and Medicines) app
TAM (Treatments and Medicines) app
  • Home
  • Feedback
  • About
  • Submit guidance
  • For Healthcare Professionals
  • For Patients and Carers
  • Notifications
Sign Out
  • Home
  • Feedback
  • About
  • Submit guidance
  • For Healthcare Professionals
  • For Patients and Carers
  • Notifications
  • Treatments and Medicines
  • For Healthcare Professionals
  • FORMULARIES (and the Pink One)
  • SHARED CARE PROTOCOLS

SHARED CARE PROTOCOLS

Previous
Print
  • Degarelix Shared Care Protocol
  • Fulvestrant Shared Care Protocol: Treatment in Metastatic Breast Cancer
  • Natalizumab (Tysabri) for multiple sclerosis: shared care protocol
  • Pentoxifylline Shared Care Protocol
  • Subcutaneous methotrexate - shared care protocol
Close

Guidance Notes

  • For Healthcare Professionals
    • COVID-19 (Coronavirus)
    • THERAPEUTIC GUIDELINES
    • ANTIMICROBIAL GUIDANCE
    • FORMULARIES (and the Pink One)
      • HIGHLAND FORMULARY INTRODUCTION
      • OTHER FORMULARIES
      • ANAESTHESIA
      • CARDIOVASCULAR SYSTEM
      • CENTRAL NERVOUS SYSTEM
      • DERMATOLOGY
      • EAR, NOSE AND OROPHARYNX
      • EMERGENCY TREATMENT OF POISONING
      • ENDOCRINE SYSTEM
      • EYE
      • GASTRO-INTESTINAL SYSTEM
      • GENITO-URINARY DISORDERS
      • IMMUNOLOGICAL PRODUCTS AND VACCINES
      • INFECTIONS
      • MALIGNANT DISEASE AND IMMUNOSUPPRESSION
      • MUSCULOSKELETAL AND JOINT DISEASE
      • NUTRITION AND BLOOD
      • OBSTETRICS AND GYNAECOLOGY
      • RESPIRATORY SYSTEM
      • SEXUAL AND REPRODUCTIVE HEALTH
      • GOOD PRESCRIPTION WRITING GUIDELINES
      • SHARED CARE PROTOCOLS
        • Degarelix Shared Care Protocol
        • Pentoxifylline Shared Care Protocol
        • Fulvestrant Shared Care Protocol: Treatment in Metastatic Breast Cancer
        • Natalizumab (Tysabri) for multiple sclerosis: shared care protocol
        • Subcutaneous methotrexate - shared care protocol
    • PATIENT INFORMATION
    • FURTHER CLINICAL RESOURCES

Powered by Quris